Dawson James                                  Jason Kolbert

H.C. Wainwright & Co.

Raghuram Selvaraju, Ph.D.
Yi Chen, Ph.D.

LifeSci Capital

Jacques A. Villefranc, Ph.D.

Maxim Group                                                    

Caroline Palomeque
Jason McCarthy, PhD.

National Securities

Jonathan Aschoff, Ph.D.

Oppenheimer & Co., Inc.

Leland Gershell, MD, Ph.D.

Roth Capital Partners

Jerry Isaacson, Ph.D.

Trickle Research

David Lavigne


John D. Vandermosten

AzurRx BioPharma, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding AzurRx BioPharma, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of AzurRx BioPharma, Inc. or its management. AzurRx BioPharma, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.